Think being outside the EU keeps your AI off the hook?
Not true: from 2026 the EU’s AI rules apply to any provider whose systems reach EU users or affect people in the Union.
That means third‑country companies must meet the same duties as EU providers: risk management, technical documentation, data quality, transparency, an EU authorized representative, and conformity assessments for high‑risk systems.
This post walks through who is covered, the core obligations, how to appoint an EU rep, and a practical step‑by‑step plan to get a high‑risk AI system certified and market‑ready by 2026.
Applicability of EU AI Act Rules to Non‑EU Providers

The EU AI Act doesn’t care where you’re based. If your AI system lands in the EU market or if EU users interact with your outputs, you’re in. A SaaS company in Seattle running a recommendation engine, a Toronto startup whose API gets embedded in an EU customer’s product, an Asian vendor selling HR screening tools to European employers—all of them answer to the Act’s full provider requirements. You don’t need an office in Brussels, a subsidiary in Berlin, or a single EU employee. What matters is market activity and EU impact.
The Act defines “provider” as anyone who develops an AI system (or commissions its development) with the intent to place it on the EU market or put it into service under their own name or trademark. That covers third‑country entities who outsource development, white‑label products, or offer systems straight through digital channels. Once your AI becomes available to EU users—through sale, licensing, free access, or API integration—you own the compliance burden: documentation, conformity assessment, risk management, market monitoring.
Extraterritorial compliance isn’t negotiable. The moment you decide to serve EU users or plug your tech into EU workflows, treat the AI Act as binding. Here’s what hits immediately:
• Full compliance duties, identical to EU‑based providers, covering lifecycle risk management, technical documentation, conformity assessments, and post‑market monitoring.
• Mandatory appointment of an EU authorized representative to handle regulatory liaison and keep documentation within the Union.
• Registration of high‑risk AI systems in the EU database before placing them on the market or putting them into service.
• Continuous monitoring of outputs and incidents, with reporting duties and update obligations whenever systems change or performance drifts.
Core Compliance Obligations for Third‑Country AI Providers

Providers in San Francisco, Toronto, Singapore, or Brussels face the same requirement: a documented risk management system spanning the entire AI lifecycle. You need to identify, analyze, and mitigate known and foreseeable risks to health, safety, and fundamental rights from design through deployment and post‑market use. Risk assessments must iterate whenever model retraining, environment changes, or incident data surface new hazards. Non‑EU providers can’t delegate this or plead ignorance of EU‑specific risk profiles. You manage risks within the Union, not just risks you’ve seen at home.
Technical documentation is non‑negotiable. Providers must prepare and maintain a comprehensive technical file describing the AI system’s intended purpose, design specs, development process, data governance measures, performance metrics, human oversight provisions, and conformity assessment results. This file stays available to EU authorities on request and gets retained for at least ten years after the last unit hits the market. Documentation can’t be an afterthought. It needs structure, version control, and integration into engineering and product workflows from day one.
Training, validation, and testing data must meet strict quality and governance standards. Data has to be relevant, representative, and free from errors and gaps that could introduce bias or compromise safety. You document data provenance, curation methods, labeling procedures, and any known limitations or demographic imbalances. When data comes from third parties or public datasets, you remain accountable for verifying its suitability and compliance with EU data protection rules, including GDPR. Non‑EU providers can’t assume that data practices acceptable at home will pass EU scrutiny.
Transparency duties require providers to ensure deployers and affected individuals can understand how the AI system operates and what to expect from its outputs. That means clear instructions for use, disclosure of known limitations, and explanations of the factors influencing decisions. For high‑risk systems like credit scoring, employment screening, or law enforcement tools, users must be informed they’re interacting with an AI system. This requirement crosses borders and applies equally to third‑country providers serving EU customers.
| Obligation | Applies to Third‑Country Providers? |
|---|---|
| Risk management system | Yes, mandatory for all providers placing systems in the EU |
| Technical documentation and retention | Yes, 10‑year retention; must be available to authorities |
| Data governance and quality standards | Yes, applies to training, validation, and operational data |
| Human oversight mechanisms | Yes, providers must design systems to enable meaningful intervention |
| Conformity assessment before market entry | Yes, self‑certification or notified body assessment required |
| Post‑market monitoring and incident reporting | Yes, continuous monitoring and corrective action duties apply |
Role and Requirements of EU Authorized Representatives

Third‑country providers placing AI systems on the EU market must appoint an authorized representative established within the Union before making any high‑risk system available to EU users. This isn’t optional and can’t be satisfied by designating a distributor, reseller, or informal contact. The appointment gets formalized through a written mandate that explicitly defines the representative’s responsibilities, scope of authority, and duration of engagement.
The authorized representative functions as your regulatory proxy within the EU. They’re the primary point of contact for national competent authorities and must be able to demonstrate you’ve fulfilled all applicable obligations. This includes verifying conformity assessments are complete, technical documentation is current and accessible, and any corrective actions or recalls execute promptly. The representative doesn’t perform the compliance work—that’s your duty—but they confirm its existence and facilitate regulatory access.
Required Responsibilities of Authorized Representatives
• Retain and make available to authorities the EU declaration of conformity, technical documentation, and the written mandate from the provider for at least ten years after the AI system hits the market.
• Provide authorities with all information and documentation necessary to demonstrate the provider’s compliance, in a language easily understood by the authority (typically the official language of the Member State).
• Cooperate with competent authorities on any request to bring the AI system into compliance or to mitigate risks, including facilitating market surveillance and corrective measures.
• Immediately inform the provider of any substantiated complaints, reports of incidents, or non‑compliance findings raised by authorities or users within the EU.
• Terminate the mandate and notify the relevant authority if the provider fails to meet its obligations or acts in breach of the AI Act, ensuring the authority can take enforcement action directly against the provider.
Conformity Assessment Steps for High‑Risk AI Systems

High‑risk AI systems can’t be placed on the EU market until you’ve completed a conformity assessment demonstrating compliance with the Act’s requirements and affixed CE marking to indicate conformity. This process is the gatekeeper for market access and applies identically to third‑country providers. No shortcuts, no deferrals, no reliance on home‑country certifications.
Conformity Assessment Process
- Classify the AI system against Annex III categories (biometric identification, critical infrastructure, employment, law enforcement, credit scoring, education) to confirm high‑risk status and determine whether internal assessment or notified body involvement is required.
- Establish a quality management system per the Act’s requirements, covering design controls, data governance, change management, documentation practices, and post‑market monitoring procedures.
- Compile the technical documentation as specified, including system description, design and development information, data governance records, risk management outputs, testing and validation reports, and instructions for use.
- Conduct internal conformity assessment (for most high‑risk categories) by verifying compliance with the essential requirements, or engage a notified body (required for certain biometric identification systems under Annex VII) to perform third‑party assessment and issue an EU technical documentation assessment certificate.
- Draw up the EU declaration of conformity, signed by you or your authorized representative, declaring that the AI system meets all applicable requirements and identifying the provider, system, and applicable harmonized standards or common specifications.
- Affix CE marking to the AI system (or its packaging, instructions, or digital interface where physical marking is impractical) to signify conformity and enable free movement within the EU.
- Register the high‑risk AI system in the EU database before placing it on the market or putting it into service, providing the information required by the registration obligations.
After conformity assessment, your obligations continue. Technical documentation and quality management records stay retained for ten years from the date the last unit gets placed on the market. Any substantial modification—retraining with new data, changes to intended purpose, algorithmic updates—triggers a new conformity assessment. You also maintain post‑market monitoring systems to track real‑world performance, collect incident data, and implement corrective actions when risks emerge or performance degrades. These duties aren’t one‑time compliance exercises but ongoing operational commitments extending throughout the system’s market life.
Importers, Distributors, and EU Market Placement Requirements

Third‑country providers often rely on importers and distributors to bring AI systems into the EU market. While you retain primary compliance responsibility, these intermediaries carry distinct verification and due diligence duties that can block non‑compliant systems from reaching EU users. An importer is the first entity in the supply chain to place a third‑country AI system on the EU market. A distributor makes the system available after import without altering its properties, performance, or intended purpose.
Importers must verify you’ve completed conformity assessment, affixed CE marking, drawn up the EU declaration of conformity, and appointed an authorized representative before placing the system on the EU market. If any of these elements is missing or defective, the importer must refuse to place the system and immediately notify you and market surveillance authorities. Importers also inherit certain provider obligations if you fail to act, including ensuring technical documentation is available, cooperating with authorities, and taking corrective action if a system presents risks.
Distributors must verify the system bears CE marking, is accompanied by required instructions and information in a language understood by users in the relevant Member State, and that you and the importer have fulfilled your obligations. If a distributor makes substantial modifications or rebrands a system under its own name, it assumes the role and obligations of the provider. This recharacterization risk matters particularly for third‑country providers who white‑label products or allow customization by EU partners.
| Actor | Primary Obligation Under EU AI Act |
|---|---|
| Third‑Country Provider | Full compliance: risk management, conformity assessment, documentation, CE marking, appointment of EU authorized representative |
| EU Authorized Representative | Regulatory liaison, document retention (10 years), cooperation with authorities, mandate termination if provider breaches Act |
| Importer | Verify provider compliance before placing on market; refuse non‑compliant systems; notify authorities; inherit provider duties if provider fails |
| Distributor | Verify CE marking and documentation; ensure language compliance; assume provider role if system is substantially modified or rebranded |
Prohibited AI Practices Affecting Global Providers

The EU AI Act bans certain AI practices outright, with no exceptions and no transitional periods beyond the Act’s initial phase‑in. These prohibitions apply globally. Any provider, regardless of location, who offers or deploys a banned AI system within the EU faces immediate enforcement risk: fines, market bans, and reputational damage. The prohibition regime took effect in February 2025, meaning third‑country providers should have already screened product portfolios and discontinued non‑compliant offerings.
Prohibited practices get defined by their purpose and effect, not by the underlying technology. A machine learning model, rule‑based system, or hybrid architecture can all fall within a ban if deployed for a prohibited use. This outcome‑oriented framing means you can’t evade restrictions by rebranding functionality, obscuring decision logic, or claiming the system is “just a tool.” What matters is how the system is used and whom it affects.
The following AI practices are banned across the EU:
• Subliminal, manipulative, or deceptive techniques that materially distort behavior and cause significant harm. Examples include AI that exploits vulnerabilities related to age, disability, or socioeconomic situation to manipulate choices (voice‑activated toys that encourage unsafe behavior, dark‑pattern interfaces targeting children).
• Social scoring by public authorities or on their behalf: systems that evaluate or classify individuals based on social behavior, personal characteristics, or predicted traits, resulting in detrimental or unfavorable treatment unrelated to the context or disproportionate to the behavior (modeled on practices used in certain non‑EU jurisdictions).
• Real‑time remote biometric identification in publicly accessible spaces for law enforcement, except in narrowly defined situations involving serious crime, immediate threats, or locating missing persons (restrictions include prior judicial or independent administrative authorization).
• Biometric categorization systems that infer sensitive attributes like race, political opinions, trade union membership, religious or philosophical beliefs, sex life, or sexual orientation, unless ancillary to lawful biometric processing (demographic filtering for accessibility).
• Exploitation of vulnerabilities due to age, disability, or specific social or economic situations to materially distort behavior in a manner that causes or is likely to cause significant harm to the individual or another person.
Enforcement Timelines and Penalties for Non‑EU Providers

The EU AI Act rolled out in phases beginning in 2025, with the most significant compliance deadlines concentrated in 2026 and 2027. For third‑country providers, this staged timeline creates a narrow window to achieve full conformity before enforcement powers are fully activated. Prohibited AI practices became enforceable in February 2025, general‑purpose AI transparency obligations began in August 2025, and the core high‑risk requirements (conformity assessment, registration, and authorized representative duties) came into force in August 2026. A final tranche of obligations, particularly those tied to Article 6(1) and legacy system grandfathering, applies in August 2027.
Enforcement is decentralized across EU Member States, with each national competent authority empowered to conduct market surveillance, order corrective action, and impose administrative fines. Non‑EU providers face the same penalties as EU‑based operators, with no jurisdictional discount or compliance grace period. Fines get calculated on global annual turnover, meaning a violation by a multinational provider triggers penalties based on worldwide revenue, not just EU sales.
The fine structure is tiered by severity. The most serious infringements (placing a prohibited AI system on the market, failing to comply with a ban, or supplying incorrect or misleading information that leads to regulatory decisions) carry fines of up to EUR 35 million or 7 percent of total worldwide annual turnover, whichever is higher. Non‑compliance with high‑risk obligations (risk management, data governance, technical documentation, conformity assessment, human oversight, post‑market monitoring) can result in fines of up to EUR 15 million or 3 percent of global turnover. Infringements related to transparency, record‑keeping, or cooperation with authorities carry fines up to EUR 7.5 million or 1.5 percent of turnover.
Key enforcement milestones for third‑country providers:
• February 2025: Prohibited AI practices enforceable; providers must cease offering banned systems in the EU and remove non‑compliant features from existing deployments.
• August 2025: General‑purpose AI transparency obligations take effect; providers of foundation models must disclose training data, capabilities, known limitations, and risk mitigation measures.
• August 2026: Full enforcement begins for high‑risk AI obligations; all conformity assessments, registrations, authorized representative appointments, and technical documentation must be complete before this date.
• August 2027: Article 6(1) obligations and final legacy‑system compliance requirements apply; any remaining transitional arrangements expire, and all AI systems on the EU market must meet the Act’s full requirements.
Final Words
In the action, this article showed how the EU AI Act reaches non‑EU providers when their systems or outputs are used in the EU and what triggers extraterritorial scope.
We covered core duties—risk management, technical documentation, training‑data rules—plus the role of EU authorized representatives, conformity steps for high‑risk systems, importer/distributor checks, and banned practices.
If you’re outside the bloc, act now: third-country ai providers compliance with eu 2026 rules means concrete processes and records. Start early and you’ll keep market access.
FAQ
Q: How does the EU AI Act apply to non‑EU providers?
A: The EU AI Act applies to non‑EU providers when their AI systems are placed on the EU market or their outputs are used in the EU; those providers face the same obligations as EU‑based entities.
Q: What triggers extraterritorial applicability under the Act?
A: Extraterritorial applicability is triggered when an AI system is made available or used within the EU, or when the provider targets EU users, regardless of the provider’s physical location.
Q: Who qualifies as a “provider” under the EU AI Act?
A: A provider is any natural or legal person that develops, supplies, or places an AI system on the market; third‑country companies performing those roles qualify as providers.
Q: What immediate obligations apply once a system is accessible in the EU?
A: Once accessible in the EU, providers must meet full provider duties including risk management, technical documentation, data governance, transparency, cybersecurity, and post‑market monitoring.
Q: What are the core compliance obligations for third‑country providers?
A: Core obligations for third‑country providers include implementing a risk‑management system, keeping technical documentation, ensuring training‑data governance, performing testing and logging, and supplying clear instructions and transparency.
Q: When must third‑country providers appoint an EU authorized representative and what do they do?
A: Third‑country providers must appoint an EU authorized representative when placing systems in the EU; the representative holds compliance files, acts as the regulator contact, and ensures documentation is available.
Q: What are required responsibilities of authorized representatives?
A: Required responsibilities of authorized representatives include keeping technical files, acting as official contact for regulators, assisting with conformity checks, supporting corrective actions, and ensuring accessibility of compliance records.
Q: What steps do high‑risk AI systems need for conformity assessment?
A: High‑risk AI systems must follow a conformity assessment process involving a quality‑management system, formal testing, notified‑body involvement when required, detailed logging, and documented compliance evidence.
Q: What must importers and distributors check for third‑country AI systems?
A: Importers and distributors must verify provider compliance, confirm the system’s conformity, ensure required documentation is available to authorities, and halt distribution if the product is non‑conforming.
Q: Which AI practices are prohibited for global providers under the Act?
A: The Act prohibits manipulative AI, social scoring, exploitative systems, and most real‑time biometric identification in public spaces, with only narrowly defined exceptions.
Q: What are the enforcement timelines and penalties for non‑EU providers?
A: Enforcement runs in phases through 2025–2026, with full high‑risk obligations in 2026; penalties can reach EUR 35 million or 7% of global annual turnover, depending on the violation.
